LRK-4189 optimization clinical trials

A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LRK-4189 Alone and in Combination in Patients With Solid Tumors

This study is testing a new medicine called LRK-4189 for adults with solid cancers that have spread. It aims to see if LRK-4189 is safe and helps shrink tumours, especially bowel cancer, either alone or with normal chemotherapy. Participants will take the drug and have regular check-ups.